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Abstract
The present study investigates whether excessive fat accumulation and hyperinsulinaemia during catch-up growth on high-fat diets are
altered by n-6 and n-3 PUFA derived from oils rich in either linoleic acid (LA), a-linolenic acid (ALA), arachidonic acid (AA) or DHA. It
has been shown that, compared with food-restricted rats refed a high-fat (lard) diet low in PUFA, those refed isoenergetically on diets
enriched in LA or ALA, independently of the n-6:n-3 ratio, show improved insulin sensitivity, lower fat mass and higher lean mass, the
magnitude of which is related to the proportion of total PUFA precursors (LA þ ALA) consumed. These relationships are best ﬁtted by
quadratic regression models (r 2 . 0·8, P,0·001), with threshold values for an impact on body composition corresponding to PUFA pre-
cursors contributing 25–30% of energy intake. Isoenergetic refeeding on high-fat diets enriched in AA or DHA also led to improved body
composition, with increases in lean mass as predicted by the quadratic model for PUFA precursors, but decreases in fat mass, which are
disproportionately greater than predicted values; insulin sensitivity, however, was not improved. These ﬁndings pertaining to the impact of
dietary intake of PUFA precursors (LA and ALA) and their elongated–desaturated products (AA and DHA), on body composition and
insulin sensitivity, provide important insights into the search for diets aimed at counteracting the pathophysiological consequences of
catch-up growth. In particular, diets enriched in essential fatty acids (LA and/or ALA) markedly improve insulin sensitivity and composition
of weight regained, independently of the n-6:n-3 fatty acid ratio.
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It has long been known from studies of nutritional rehabilita-
tion in malnourished humans and other mammals that the
recovery of body fat occurs at a disproportionately faster
rate than that of lean tissue deposition(1,2), independently of
the level of dietary energy or protein supplementation(1,3,4).
This phenomenon of preferential catch-up fat, with lean
tissue recovery lagging, has been demonstrated not only
during weight recovery in adults who have lost weight in
response to poverty and famine-related malnutrition(1–4),
anorexia nervosa(5) and disease-related cachexia(6–8), but
also during nutritional rehabilitation of undernourished chil-
dren(9–12) and in young adolescents recovering from anorexia
nervosa(13,14). In more recent years, there has also been a
resurgence of interest into this phenomenon of preferential
catch-up fat in infants and younger children, primarily
because its occurrence concomitant to hyperinsulinaemia
during catch-up growth(15–19) is viewed to be of central
importance in the mechanisms by which catch-up growth
predisposes to obesity, type 2 diabetes and CVD later in
life(20–22). Consequently, approaches that redirect nutrient
partitioning from preferential catch-up fat to enhanced lean
tissue accretion are of potential value as much as for protec-
tion against disease risks associated with catch-up growth
after fetal or neonatal malnutrition, as for improving the
recovery of lean tissue (and hence functional recovery) after
malnutrition at any stage of growth.
However, progress in this ﬁeld of nutritional energetics and
body composition regulation has been limited by the necessity
for precise determinations of body composition and concomi-
tant measurements of energy balance in a dynamic state of
weight gain. In addition, because differences in the level of
energy intake tend to obscure effects due to diet composition
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per se, the impact of various dietary formulations on lean and
fat tissue deposition during weight recovery is often difﬁcult to
interpret.
In search for approaches that could alter nutrient partition-
ing during catch-up growth, we have therefore utilised rats as
a model of food restriction–refeeding(23,24) which, similar to
human infants and children showing catch-up growth, exhibit
preferential catch-up fat associated with hyperinsulinaemia. In
this animal model, both catch-up fat and hyperinsulinaemia
can be demonstrated during refeeding on a low-fat (chow)
diet in the absence of hyperphagia, and are exacerbated by
isoenergetic refeeding on a high-fat (HF-lard) diet(24,25). In
an earlier investigation into the inﬂuence of dietary fat types
on the composition of weight regained, we found that the
exacerbation of fat deposition shown with certain dietary
fats (lard, olive oil and menhaden ﬁsh oil) does not occur
with coconut oil (rich in medium-chain fatty acids) or in saf-
ﬂower oil which is rich in n-6 PUFA(26). Although diets high
in these fatty acids are well known to be more thermogenic
and less fattening during spontaneous growth than diets
high in long-chain SFA(27–29), an unexpected outcome of
our previous study(26) is that it revealed that the efﬁcacy of
safﬂower oil in limiting catch-up fat resided in minor part
through increased thermogenesis, with the major effect in
reducing body fat attributed to a shift in energy partitioning
in favour of lean tissue accretion.
Given that n-6 PUFA, essentially as linoleic acid (LA),
account for more than two-thirds of total fatty acids in saf-
ﬂower oil, the primary objective of the study reported here
was to gain further insights into the role of diets rich in the
two essential fatty acids, LA and a-linolenic acid (ALA), as
well as their elongated and desaturated products arachidonic
acid (AA) and DHA, in the modulation of body composition
and whole-body insulin sensitivity during catch-up growth.
The following speciﬁc questions were addressed: (1) is the
dual effect on lean and fat mass obtained with safﬂower oil
also observed with other oils rich in LA, such as maize oil, sun-
ﬂower oil and grapeseed oil in which LA accounts for .40%
of total fatty acids; (2) is there a dose–response relationship
between dietary LA content and lean mass accretion during
catch-up growth, and what would be the threshold level of
dietary LA that would enhance the gain in protein mass
during catch-up growth; (3) is the stimulatory effect of LA
modiﬁed by partial substitution with ALA and hence by the
n-6:n-3 fatty acid ratio; (4) is the enhanced lean mass observed
with LA-rich safﬂower oil mimicked by oils rich in AA (a major
metabolite of LA) or by DHA (a major metabolite of ALA); (5)
what would be the impact of HF diets rich in these essential
fatty acids (LA and ALA) or in their major metabolites (AA
and DHA) on blood glucose homeostasis?
Materials and methods
General study design
All experiments were performed in male Sprague–Dawley rats
(Elevage Janvier, St Bertherin, France). The rats, aged 6 weeks,
were adapted to room and cage environments for at least 5 d
before the start of each experiment; they were caged singly in
a temperature-controlled room (22 ^ 18C) with a 12 h light–
12 h dark cycle. They were maintained on a commercial pel-
leted chow diet (Kliba; Provimi-Lacta, Cossonay, Switzerland)
consisting, by energy, of 24% protein, 66% carbohydrates and
10% fat, and had free access to tap water. The experiments
were conducted after this period of adaptation in rats selected
on the basis of body weight being within ^5 g of the mean
body weight (i.e. between 235 and 245 g). As in previously
reported studies from our laboratory(24–26), they were food
restricted for 2 weeks at approximately 50% of their spon-
taneous ad libitum daily food intake. At the end of the food
restriction period, groups of animals of similar mean body
weight were refed a ﬁxed ration of the various test diets at a
level approximately equal in metabolisable energy content
to the normal intake of non-restricted (control) animals, i.e.
85 kcal (355 kJ) of the test diet that corresponds to 28 g of
chow daily per animal. During all refeeding experiments,
the diets were provided in food containers secured to the
back of the cage in a way that prevented food spillage, and
each animal consumed the test diet provided during the
refeeding period. After 2 weeks of energy-controlled refeed-
ing, all animals were killed, and their carcasses were analysed
for body composition as described below. Animals used in the
present studies were maintained in accordance with our insti-
tute’s regulations and guide for the care and use of laboratory
animals, and all experimental procedures were performed
under conditions approved by the Ethical Committee of the
State of Fribourg Veterinary Ofﬁce.
Diets
The test oils were incorporated into semi-synthetic and syn-
thetic diets whose nutrient compositions are shown in
Table 1. For the semi-synthetic diets, the fatty acid proﬁle of
both chow and test oils was analysed by GC as detailed
below. The overall fatty acid composition of the HF diets,
determined from the fatty acid composition of both test oil
and basal mixture, and expressed as SFA, MUFA and PUFA,
is presented in Table 2. The energy digestibility of the test
diets was determined during preliminary studies, which
involved feeding groups of three animals each of the test
diets over 5 d (after a period of food restriction as described
above), measuring food intake and collecting faeces; any
food spilled was collected, dried and weighed, and suitable
corrections were made to the gross food intake. From
energy density of diets and faeces measured by bomb calori-
metry(30), the values for energy digestibility were found to
be similar, varying between 86·2 and 86·8% of energy
intake. The various food ingredients were purchased from
the following sources: ground standard chow (Provimi-
Lacta); vitamin-free casein, DL-methionine and choline chlor-
ide (Sigma, St Louis, MO, USA); American Institute of Nutrition
(AIN)-76 vitamin mixture and AIN 76 mineral mixture were
purchased from MP Biomedicals (Cleveland, OH, USA); rape-
seed oil, maize oil, sunﬂower oil, grapeseed oil and safﬂower
oil were purchased from local supermarkets (Migros/Coop,
Fribourg, Switzerland); safﬂower oil and linseed oil were
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Table 1. Composition of high-fat diets
Semi-synthetic diets
Diet composition (g/100 g diet)
Basal mix*
Chow 59·0
Casein 10·8
L-Met 0·1
Sunﬂower oil 1·4
AIN mineral mix 1·7
AIN vitamin mix 0·5
Choline chloride 0·1
Test fat/oil† 26·4
List of test fat/oils†
Lard
Rapeseed oil
Maize oil
Sunﬂower oil
Grapeseed oil
Linseed oil
Safﬂower oil – S1
Safﬂower oil – S2
Safﬂower oil – S3
ARASCO
DHASCO
Nutrient composition (% ME)
Protein 21·0
Fat 58·2
Carbohydrates 20·8
ME density (kJ/g diet)§ 19·97
Synthetic diets
Diet composition§ (g/100 g diet)
Casein 18·0
L-Cys 0·25
Mineral mix 4·5
Vitamin mix 1·3
tert-Butylhydroquinone 0·08
Choline bitartrate 0·25
Cellulose 6·5
Sucrose 10
Maize starch 32·1
Oil mix 27
Composition of oil mix‡ (g/27g total) Diet 1 Diet 2 Diet 3 Diet 4
Coconut oil 2·59 5·43 12·5 12·9
Maize oil 0·01 0·03 0·80 1·75
Palm olein 0·27 6·27 6·40 5·54
Rapeseed oil 4·38 1·29 1·93 1·54
Linseed oil 0 1·79 0·64 5·30
Safﬂower oil 19·6 12·2 4·69 0
Nutrient composition‡ (% ME)
Protein 15·4
Fat 52
Carbohydrates 32·6
ME density (kJ/g diet)§ 19·6
AIN, American Institute of Nutrition; ARASCO, arachidonic acid single cell oil; DHASCO, docosahexaenoic acid
single cell oil; ME metabolisable energy.
* The basal mix provides 50% of total energy content, and its fat content contributes 8·2% of energy content
(1·5% from SFA, 2·6% as MUFA, 4·1% as PUFA).
† The added fat was either lard (control diet) or test oils richer in PUFA, and provides 50% of total dietary energy
content. S1, S2 and S3 refer to safﬂower oil purchased from three different commercial sources: S1, Migros,
Fribourg, Switzerland; S2, Coop, Fribourg, Switzerland; S3, MP Biomedicals (Cleveland, OH, USA).
‡ The diet ingredients were purchased from companies in Switzerland: casein (Schweizerhall, Basel; L-cysteine
(Fluka, Buchs, Switzerland); AIN-93 M mineral mix and AIN-93 M vitamin mix (Socochim, Lausanne); sucrose
(Howeg, Bussigny, Switzerland); coconut oil, maize oil, palm olein, safﬂower oil and rapeseed oils (Soﬁnol SA,
Manno); linseed oil (Sabo, Manno); cellulose (Christ water Technology, Basel). Maize starch and choline
bitartrate were purchased from Synopharm (Bars bu¨ttel, Germany).
§ME density was estimated by computation using values (kJ/g) for the ME content of chow, 13·01; fat/oil, 37·66;
carbohydrates, 16·736; protein, 16·736.
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also purchased from MP Biomedicals; the microbial oils
arachidonic acid single cell oil (ARASCO) and docosa-
hexaenoic acid single cell oil (DHASCO) were obtained
from Martek Bioscience Corporation (Columbia, MD, USA).
DHASCO refers to a mixture of an oil extracted from the
unicellular alga Crypthecodinium cohnii and high-oleic
sunﬂower oil, and contains about 40% of product weight as
DHA. ARASCO refers to a mixture of an oil extracted from
the unicellular fungus Mortierella alpina and high-oleic sun-
ﬂower oil, and contains about 40% AA by weight. There are
no detectable amounts of EPA in ARASCO or DHASCO.
Body composition analysis
After the animals were killed by decapitation, the skull, thorax
and abdominal cavity were incised, and the gut was cleaned
of undigested food. The whole carcasses were dried to a con-
stant weight in an oven at 708C and were subsequently
homogenised for the analysis of fat content by the Soxhlet
extraction method as described previously(23,24); the dry lean
mass (a proxy of protein mass) was determined by subtracting
total body fat and body water content from body weight.
Fatty acid analysis
Total lipids of diet (50mg), adipose tissue (50mg) and liver
(300mg) were extracted according to the method of Folch
et al.(31) in the presence of triheptadecanoin as an internal
standard (Avanti, Alabaster, AL, USA). Total lipids of muscle
(300mg) were extracted by the method of Srivastava
et al.(32), using methanol and chloroform sequentially in
the volume ratio of 1:3 and in the presence of diheptade-
canoyl-sn-glycero-3-phosphocholine as an internal standard
(Avanti). The extracted lipids were transesteriﬁed to their
methyl esters in a 3% H2SO4 methanolic reagent for 3 h at
808C, extracted with hexane, dried under N2 and resuspended
into hexane. Fatty acid methyl ester separation was performed
by automated GLC (Hewlett Packard 6890 series; Waldbronn,
Germany) using a ﬂame ionisation detector (2808C) and a BPX
70 column (30m £ 0·22mm internal diameter £ 0·25mm thick-
ness). A standard mixture (GLC-36 Nestle´; Nu-Check-Prep,
Elysian, MN, USA) of fatty acid methyl esters was also injected
to identify fatty acid methyl ester peaks. Fatty acid concen-
trations in diets were determined on a weight basis by com-
paring GLC peak area to the internal standard. Fatty acid
concentrations in tissues were calculated as percentages of
total fatty acids by comparing GLC area of each fatty acid to
the total fatty acids.
Glucose tolerance tests
Glucose tolerance tests were performed between days 12 and
14 of refeeding, according to the protocol described pre-
viously(24). Food was removed early in the morning (07.00
hours). At 6–7 h later, i.e. in the post-absorptive phase,
blood was drained from the tail vein and immediately
Table 2. Fatty acid composition of high-fat (HF) diets (as a percentage of dietary
energy content) in experiments (a) varying in oils rich in linoleic acid (LA) and/or
a-linolenic acid (ALA), (b) varying in the ratio of safﬂower oil and linseed oil (S:L),
(c) varying in PUFA and SFA, but with MUFA constant, or (d) varying in the ratio of
arachidonic acid and docosahexaenoic acid single cell oils (A:D)
SFA MUFA PUFA n-6 PUFA* n-3 PUFA*
(a) Study I
HF-lard 25·1 24·8 8·2 7·3 0·9
HF rapeseed oil 5·5 35·0 17·8 13·4 4·4
HF maize oil 8·1 20·0 30·0 29·1 0·9
HF sunﬂower oil 7·4 16·2 34·5 33·8 0·6
HF grapeseed oil 7·8 11·9 38·3 37·6 0·7
HF safﬂower oil – S1 7·5 11·8 38·8 38·0 0·8
HF safﬂower oil – S2 7·2 9·8 41·1 40·5 0·6
HF safﬂower oil – S3 6·8 9·4 42·0 41·3 0·6
(b) Study II and IV
HF S:L (1:0) 6·0 9·1 43·1 41·0 2·10
HF S:L (0:1) 6·0 12·1 40·1 15·5 24·6
HF S:L (1:1) 6·0 10·6 41·6 28·5 13·1
HF S:L (2:1) 6·0 10·1 42·1 32·5 9·6
HF S:L (1:2) 6·0 11·1 41·1 24·5 16·6
(c) Study III
Diet 1 8·5 10·7 30·8 30 0·75
Diet 2 17·3 10·7 22·0 20 2·0
Diet 3 28·3 10·7 11·0 10 1·0
Diet 4 28·3 10·7 11·0 5·5 5·5
(d) Study V
HF A:D (0:1) 15·0 18·2 24·8 – 20
HF A:D (1:3) 14·9 17·8 25·7 5 15
HF A:D (1:1) 14·5 16·7 27·1 10 10
HF A:D (3:1) 14·0 15·7 28·3 15 5
HF A:D (1:0) 14·0 14·9 29·1 20 –
*For the diets in parts (a), (b) and (c), n-6 PUFA and n-3 PUFA are LA and ALA, respectively.
For the diet in part (d), n-6 PUFA and n-3 PUFA are arachidonic acid and DHA, respectively.
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followed by an intraperitoneal injection of glucose (2 g/kg
body weight). At intervals of 30min for the next 2 h period,
blood samples were taken from the tail vein in heparinised
tubes and transferred on ice. The blood samples were then
centrifuged, and the plasma was frozen and stored at 2208C
for later assays of plasma glucose and insulin. Plasma glucose
was determined using a Beckman glucose analyser (Beckman
Instruments, Palo Alto, CA, USA), while plasma insulin was
assessed using a rat insulin ELISA kit (Crystal Chem, Inc.,
Downer’s Grove, IL, USA).
Data analysis and statistics
All data are presented as means with their standard errors. In
general, the data were analysed by one-way ANOVA, followed
by post hoc pairwise comparisons using Scheffe´’s test after
ANOVA had established signiﬁcant differences. Data collected
over time (i.e. growth and food intake) were analysed by
ANOVA with repeated-measures design. The statistical treat-
ment of data was performed using the computer software
STATISTIK 8 (Analytical Software, St Paul, MN, USA).
Results
Rat model of catch-up fat during refeeding after food
restriction
As reported previously (24–26), the rats were studied in an
age range characterised by a high rate of weight gain for
spontaneously growing controls (Fig. 1(a)). During the food
restriction period (Fig. 1(b)), the ﬁxed ration diet of 14 g
chow daily represented approximately 50% of their spon-
taneous ad libitum daily food intake. The body weights of the
food-restricted rats (between 234 and 238 g) were only slightly
and non-signiﬁcantly reduced relative to their weights at the
onset of the food restriction period (Fig. 1(b)). Comparison of
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Fig. 1. (a) Growth proﬁle and daily food intake of male Sprague–Dawley rats maintained ad libitum on a standard chow diet between the age of 3 and 25 weeks
under conditions of our laboratory. The rectangular dotted line encloses the age range (7–11 weeks) and growth period pertaining to our studies of food restriction
and refeeding, and during which the rats show rapid increases in body weight (P,0·001). Within this age range of 7–11 weeks, food intake (28 g chow daily) was
not signiﬁcantly different across time, such that providing 14 g chow daily corresponds to a 50% reduction of ad libitum food intake throughout this period. (b) Rat
model of food restriction–refeeding: After growth arrest due to food restriction, refeeding ad libitum leads to hyperphagia (þ10% higher food intake than controls,
P,0·01) and catch-up growth in both lean body mass (P,0·01) and fat mass (P,0·001). Prevention of hyperphagia by providing the refed animals with the
same amount of food as controls (i.e. 28 g chow daily) still results in catch-up in fat mass (P,0·01) but not in lean body mass. Values are means, with standard
errors represented by vertical bars ((a) n 10; (b) n 6). –X–, Control ad libitum; –W–, refed normophagic; –P–, refed hyperphagic.
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the body composition of groups of animals at the onset and at
the end of the 2-week food restriction period shows signiﬁcant
reductions in body fat (250%, P,0·01) but not in dry lean
mass. Refeeding the animals with the same amount of food as
controls (i.e. 28 g chow daily) results in greater gain in fat
mass (P,0·01), but not in lean body mass, relative to controls,
which is hence in line with our previous demonstrations of an
increased metabolic efﬁciency directed at catch-up fat in this
rat model of energy-controlled refeeding(23,24).
Study I: screening of oils rich in linoleic acid
In study I, two separate experiments were conducted during
which groups of food-restricted animals (n 6–8) were refed
isoenergetic amounts of HF diets in which the main source
of fat was derived either from safﬂower oil, sunﬂower oil,
maize oil or from grapeseed oil, i.e. oils in which LA contrib-
uted .40% of total fatty acids. In each experiment, these HF
diets were compared with one group refed isoenergetically on
a HF-lard (control) diet.
Expt 1: comparison across safﬂower oils
The speciﬁc aim of the ﬁrst experiment was to test whether
safﬂower oils obtained from three different commercial
sources were all equally capable of altering body composition
during refeeding. The total n-6 PUFA (essentially LA) content
of these three safﬂower oils varied between 69 and 76%, and
LA contributed 38, 40·5 and 41·3% of dietary energy content in
HF safﬂower – S1, HF safﬂower – S2 and HF safﬂower – S3,
respectively (Table 2, part a). The results obtained for body
composition are shown in Table 3. They were all effective in
increasing lean mass and reducing body fat relative to the
HF-lard diet, but the highest lean mass and lowest fat mass
were achieved with the HF safﬂower diet (S3) with the highest
LA content (41·3%). Conversely, the HF safﬂower oil diet (S1)
with the lowest LA content (38%) resulted in a less marked
effect on body composition.
Expt 2: comparison with other oils rich in linoleic acid
In the second experiment that screened other oils rich in LA,
refeeding was conducted with the HF diets made either
from safﬂower oil (S3), grapeseed oil, sunﬂower oil or from
maize oil, in which LA contributed between 29 and 41% of
dietary energy content (Table 2, part a). They were compared
with the HF diets rich in lard or in rapeseed oil, both of which
contain ,20% LA. The results, presented in Table 4, indicate
that the HF diets made from grapeseed oil or sunﬂower oil,
and to a lesser extent from maize oil, resulted in higher lean
mass, lower fat mass and lower fat:lean ratio relative to the
HF diets made from lard or rapeseed oil. However, these
data also indicate that HF safﬂower oil was more effective
than either grapeseed oil or sunﬂower oil in increasing lean
mass and reducing fat mass, as indicated by the lowest fat:lean
ratio obtained with the HF safﬂower oil diet compared with
the other LA-rich diets. Thus, while all HF diets rich in LA
had an impact on body composition, their effects varied as a
function of their LA content within the range of 29–41%.
Study II: linoleic acid v. a-linolenic acid
This experiment examined the extent to which the changes in
body composition observed with the HF safﬂower oil diet
would persist if the high LA content were reduced at the
expense of an increase in ALA. This was achieved by mixing
various proportions of safﬂower oil and linseed oil in HF
diet preparations, such that, as shown in Table 2 (part b),
the ratio of LA:ALA (and hence the n-6:n-3 ratio) can be mark-
edly varied while maintaining the total PUFA (LA þ ALA) con-
tent at 40–43% of dietary energy content of the HF diets. The
results on body weight and body composition after 2 weeks of
isoenergetic refeeding (Table 5) indicate that they were all
equally effective in increasing lean mass and in reducing
body fat or the fat:lean ratio when compared with the HF-
lard control diet. These changes are also reﬂected in an
increase in mass of organs and tissues of the lean body
mass (skeletal muscle, heart, liver and kidney) and in a
decrease in both epididymal and retroperitoneal fat pad
mass (Table 6). The application of ANOVA speciﬁcally to
groups refed diets high in PUFA shows no signiﬁcant differ-
ences in body composition or in organ/tissue mass across
these HF diets. Similarly, a test of glucose tolerance conducted
in the groups refed HF-lard, HF safﬂower oil, HF linseed or a
mixture of HF safﬂower and linseed oils on the last day of this
experiment also indicates that refeeding on diets high in LA or
Table 3. Effects of isoenergetic high-fat (HF) diets made from safﬂower oil from various sources on body weight and body composition
(Mean values with their standard errors, n 8)
Body composition
Body weight (g) Water (g) Fat (g) Lean (g) Fat:lean
Group HF diet Mean SE Mean SE Mean SE Mean SE Mean SE
1 HF lard 362 5 228 5 56·1a 2·4 78·2a 0·9 0·72a 0·04
2 HF safﬂower – S1* 354 4 216 4 52·2a,b 2·4 85·3b 2·0 0·62a,b 0·04
3 HF safﬂower – S2* 364 7 224 7 49·6a,b 2·3 90·2b 1·6 0·55b 0·03
4 HF safﬂower – S3* 370 5 233 6 45·2b 2·0 91·6c 0·9 0·49b 0·03
ANOVA NS NS P,0·02 P,0·001 P,0·001
a,b,cMean values with unlike superscript letters were signiﬁcantly different by a post hoc pairwise comparison (P,0·05).
* S1, S2 and S3 refer to safﬂower oil purchased from three different commercial sources.
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ALA resulted in similarly lower insulin response than refeeding
on the HF-lard diet, with these reductions being signiﬁcant
over the time period of 30–90min after the glucose load,
and when assessed as area under the curve (Table 5).
Plasma glucose proﬁle and area under the curve for plasma
glucose did not differ across the four groups. Thus, these
results suggest that it is the total intake of PUFA precursors
(LA þ ALA), rather than the speciﬁc intake of LA or ALA,
that has an impact on body composition and insulin sensitivity
during refeeding.
Study III: high PUFA v. low MUFA
As indicated in Table 2 (parts a and b), the variation in PUFA
content is inversely related to that in MUFA þ SFA content,
and more speciﬁcally related (r 2 0·79; P,0·001) to variations
in MUFA content given that SFA content is relatively constant.
To delineate variations in high PUFA from those lower in
MUFA, groups of animals were refed synthetic HF diets
which were formulated so that PUFA content varied between
11 and 31%, but with the contribution of MUFA being kept at
a low but constant level of about 11% (Table 2, part c). This
diet formulation also resulted in a wide range in the ratio of
n-6:n-3 fatty acids, namely between 1 and 40. The results of
refeeding these test diets in isoenergetic amounts for 2
weeks on body weight and body composition are presented
in Table 7. Compared with the group refed the diet with
low PUFA content (group 4), only the group refed the HF
diet with the highest PUFA content (group 1) showed signiﬁ-
cantly higher ﬁnal weight (þ7–10%), body water (þ6%) and
lean mass (þ8%), and lower body fat (212 to 217%).
Study IV: fatty acid proﬁling in organs/tissue
To examine the extent to which refeeding diets enriched with
LA, ALA or both have an impact on the proportion of these
essential fatty acids and their metabolites in key peripheral tis-
sues and organs, a study was conducted to assess the fatty acid
composition of the liver, white adipose tissue (epididymal)
and skeletal muscle (gastrocnemius). These tissues/organs
were harvested from groups of rats refed for 9 d on HF diets
enriched either with lard, safﬂower oil, linseed oil or with a
1:1 mixture of safﬂower and linseed oils (Table 2, part b),
and the fatty acid analysis of these tissues/organs was per-
formed (Table 8). Compared with animals refed the HF-lard
diet, those refed either one of the three PUFA-enriched diets
Table 4. Effects of isoenergetic high-fat (HF) diets from various oils rich in linoleic acid on body weight and body composition
(Mean values with their standard errors, n 6)
Body composition
Body weight (g) Water (g) Fat (g) Lean (g) Fat:lean
Group HF diet Mean SE Mean SE Mean SE Mean SE Mean SE
1 HF lard 366 3 231 3 57·1a 2·2 77·9a 0·6 0·73a 0·03
2 HF rapeseed 367 5 232 6 56·3a 3·1 79·1b 1·3 0·72a 0·05
3 HF safﬂower 367 2 232 3 45·0a 1·2 90·2b 0·5 0·50b 0·01
4 HF grapseed 359 4 220 6 52·7a 3·6 86·3a,b 1·8 0·62a,b 0·06
5 HF sunﬂower 367 3 230 4 48·5a 2·4 87·5b 1·5 0·56a,b 0·04
6 HF maize 357 3 223 4 53·3a 1·6 80·8a,b 0·9 0·66a,b 0·02
ANOVA NS NS P,0·01 P,0·001 P,0·001
a,bMean values with unlike superscript letters were signiﬁcantly different by a post hoc pairwise comparison (P,0·05).
Table 5. Effect of high-fat (HF) diets made from different ratios of safﬂower oil (S) and linseed oil (L) on body weight and body composition, as well as
on plasma glucose and insulin in response to a glucose load
(Mean values with their standard errors, n 8)
Body composition Glucose tolerance test*
Body
weight (g) Water (g) Fat (g) Lean (g) Fat:lean
Glucose
(AUC)†
Insulin
(AUC)†
Group HF diet Mean SE Mean SE Mean SE Mean SE Mean SE Mean SE Mean SE
1 HF lard 362 3 232 3 51·3a 1·1 78·3a 0·8 0·66a 0·02 5503 360 381a 40
2 HF S:L (1:0) 370 3 239 4 41·3b 0·9 89·6b 0·7 0·46b 0·01 5539 444 180b 46
3 HF S:L (0:1) 369 3 238 4 43·4a,b 2·1 87·7b 1·2 0·50b 0·03 5098 473 201b 22
4 HF S:L (1:1) 363 6 232 6 42·9b 1·6 88·0b 1·5 0·49b 0·02 5706 914 196b 46
5 HF S:L (2:1) 369 5 239 6 40·4b 1·9 89·9b 0·7 0·45b 0·02 – – – –
6 HF S:L (1:2) 369 2 238 3 41·6b 2·1 88·9b 0·6 0·47b 0·02 – – – –
ANOVA NS NS P,0·002 P,0·001 P,0·001 NS P,0·01
a,bMean values with unlike superscript letters were signiﬁcantly different by post hoc pairwise comparison (P,0·05).
*Glucose tolerance test was conducted only in groups 1–4.
†AUC refers to the area under the curve for plasma glucose (mg/ 100ml per 2 h) or insulin curve (ng/ml per 2 h) above baseline (pre-glucose load) plasma levels.
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show a higher proportion of tissue fatty acids as total PUFA at
the expense of lower proportions as SFA and MUFA, irrespec-
tive of the organ/tissue studied. These increases in tissue PUFA
as n-6 PUFA or n-3 PUFA reﬂect the content of the diet
enriched in LA or ALA, respectively. Thus, relative to the
HF-lard group, the groups that consumed LA-enriched diets
with safﬂower oil show increases in tissue LA that account
for more than 80% of the increase in n-6 PUFA in the liver,
muscle and adipose tissue. Similarly, in the groups that con-
sumed the ALA-enriched diets with linseed oil, the increase
in tissue ALA accounts for most (78–95%) of the increase in
n-3 PUFA in adipose tissue and skeletal muscle. In the liver,
however, ALA and ALA metabolites accounted for about
50% each for the increase in total n-3 PUFA in animals con-
suming the ALA-enriched diets, with EPA and DHA in turn
accounting for about two-thirds of the increase in ALA metab-
olites. Furthermore, whereas EPA was signiﬁcantly increased
in all three tissues of animals refed the ALA-enriched diets, a
signiﬁcant increase in DHA only occurred in the adipose
tissue. Similarly, AA, a main metabolite of LA, was found to
be signiﬁcantly higher only in adipose tissue of the group
refed the LA-enriched diet with safﬂower oil compared with
the HF-lard group.
Study V: high arachidonic acid and DHA oils
To test whether the effect of HF diets based on oils rich in
LA and/or ALA on body composition and insulin sensitivity
could be mimicked by oils rich in their elongated products
(AA or DHA, respectively), refeeding studies were conducted
to assess the impact of HF diets based on microbial oils
ARASCO and DHASCO (rich in AA) or DHASCO (rich in
DHA) or mixtures of ARASCO and DHASCO to yield different
ratios of AA:DHA, as indicated in Table 2 (part d). The results
of these experiments comparing HF diets containing iso-
energetic amounts of either lard, a 1:1 mixture of safﬂower
and linseed oils, ARASCO or DHASCO are presented in
Table 9. They indicate that, compared with the HF-lard diet,
refeeding either the HF ARASCO or HF DHASCO diet resulted
in a marked decrease in body fat by 18–24% and a marginal
increase in lean mass (þ5%). Another study comparing diets
with different proportions of ARASCO and DHASCO showed
no signiﬁcant differences in body composition in animals
refed on these diets (Table 10). By contrast, these studies indi-
cate that diets in which the fat was derived primarily from
ARASCO resulted in signiﬁcantly raised plasma glucose con-
centrations during the test of glucose tolerance compared
with the other oils; this being reﬂected in the area under the
Table 6. Organ/tissue mass after refeeding with high-fat (HF) diets made from lard, safﬂower oil (S), linseed oil (L) or a 1:1 mixture of these two oils
(Mean values with their standard errors, n 8)
Adipose tissue* (g) Skeletal muscle† (g) Heart (g) Liver (g) Kidney (g)‡
Group HF diet Mean SE Mean SE Mean SE Mean SE Mean SE
1 HF lard 6·72a 0·13 2·83a 0·03 0·96a 0·02 11·4a 0·17 1·14a 0·02
2 HF S:L (1:0) 5·61b 0·10 2·99b 0·05 1·01a 0·01 12·3b 0·25 1·21b 0·02
3 HF S:L (0:1) 5·50b 0·26 3·01b 0·04 0·99a 0·01 12·2b 0·16 1·21b 0·01
4 HF S:L (1:1) 5·63b 0·13 2·99b 0·05 1·00a 0·02 12·4b 0·13 1·22b 0·02
ANOVA P,0·001 P,0·01 P,0·05 P,0·01 P,0·01
a,bMean values with unlike superscript letters were signiﬁcantly different by a post hoc pairwise comparison (P,0·05).
* Sum of epididymal and retroperitoneal fat pads.
†Sum of gastrocnemius, tibialis anterior and soleus muscles.
‡Sum of both kidneys.
Table 7. Effects of various isoenergetic high-fat (HF) synthetic diets (1–4) differing in PUFA and SFA, but with MUFA constant, on body weight and
composition*
(Mean values with their standard errors, n 6)
Body composition
Diet Body wt (g) Water (g) Fat (g) Lean (g) Fat:lean
Group†
PUFA
(% diet energy)
n-6:n-3
(LA:ALA) Mean SE Mean SE Mean SE Mean SE Mean SE
1 31 40:1 371 1 239a 2 47·1a 1·5 84·7a 0·4 0·56a 0·02
2 22 10:1 362 2 226b 2 56·7b 2·5 79·2b 0·7 0·72b 0·04
3 11 10:1 364 3 232a,b 3 53·7a,b 1·5 78·1b 1·0 0·69b 0·03
4 11 1:1 361 4 229a,b 5 55·0a,b 1·4 77·3b 0·9 0·71b 0·02
HF lard (positive control) 366 5 234 5 55·3 1·8 78·6 0·9 0·68 0·04
ANOVA P¼0·07 P,0·05 P¼0·01 P,0·001 P,0·01
LA, linoleic acid; ALA, a-linolenic acid.
a,bMean values with unlike superscript letters were signiﬁcantly different by a post hoc pairwise comparison (P,0·05).
* An additional group refed on a HF-lard semi-synthetic diet was added as a positive control.
† In addition to the groups (1–4) refed on synthetic diets, another group refed isoenergetically on a HF-lard (semi-synthetic) diet has been added as a positive control, and is
not included in the statistical analysis of data for the groups (1–4) refed the synthetic diets.
y yp p g

ht
tp
://
do
c.
re
ro
.c
h
curve for plasma glucose (Tables 9 and 10). Furthermore,
unlike the HF diet enriched in LA þ ALA, the diets high in
ARASCO or DHASCO did not result in a signiﬁcantly lower
plasma insulin response curve below that of the HF-lard
group (Tables 9 and 10).
Discussion
Using the same rat model of restriction–refeeding as in the
present study, it has previously been reported(26) that, com-
pared with refeeding on a low-fat diet, isoenergetic refeeding
on HF diets in which 50% of energy intake was derived from
either lard, olive oil or menhaden ﬁsh oil resulted in a higher
efﬁciency of fat deposition and excessive adiposity, effects
which, however, were not observed when the dietary fat
was derived from safﬂower oil. In fact, refeeding on the saf-
ﬂower oil diet not only prevented the excessive fat deposition,
but also resulted in a higher lean body mass, a dual effect on
body composition that is reproduced in our studies here not
only with safﬂower oils from various commercial sources,
but also with other oils that are rich either in LA (sunﬂower,
grapeseed and maize), in ALA (linseed) or in various mixtures
of LA and ALA (obtained by mixing safﬂower and linseed oils).
Taken together, these ﬁndings show that it is the total PUFA
Table 8. Fatty acid proﬁle in tissues/organs after 9 d of refeeding with high-fat diets made from lard, safﬂower oil,
linseed oil or a 1:1 mixture of these two oils*
(Mean values with their standard errors, n 6)
Lard Safﬂower Linseed Mix (1:1)
Mean SE Mean SE Mean SE Mean SE ANOVA
Muscle
Total SFA 35·0a 0·6 29·3b 1·8 27·7b 1·7 26·4b 0·9 P¼0·001
Total MUFA 29·5a 2·7 17·4b 1·7 18·8b 2·0 18·7b 1·3 P¼0·001
Total PUFA 35·5a 2·2 53·3b 0·7 53·6b 0·4 54·9b 0·5 P,0·0001
PUFA n-6 27·9a 1·3 46·7b 1·2 30·3a 1·0 38·1c 0·5 P,0·0001
C18 : 2n-6 (LA) 18·3a 0·4 34·6b 2·9 22·4a 0·5 29·9c 0·6 P,0·0001
C18 : 3n-6 – – – – – – – – –
C20 : 3n-6 0·4 0·0 0·4 0·0 0·3 0·0 0·3 0·0 NS
C20 : 4n-6 (AA) 8·5 1·0 10·4 1·7 7·1 1·0 7·3 0·7 NS
C22 : 4n-6 0·7a 0·1 1·2b 0·2 0·3c 0·0 0·4c 0·0 P,0·0001
PUFA n-3 7·6a 0·9 6·6a 0·9 23·3b 0·7 16·9c 0·3 P,0·0001
C18 : 3n-3(ALA) 0·9a 0·1 0·5a 0·1 13·3b 2·0 8·3c 0·8 P,0·0001
C20 : 5n-3 (EPA) 0·1a 0·0 - - 1·04b 0·1 0·4c 0·0 P,0·0001
C22 : 5n-3 1·2a 0·2 1·1a 0·2 2·6b 0·4 2·1b 0·2 P,0·001
C22 : 6n-3 (DHA) 5·4 0·8 5·1 0·8 6·1 0·9 6·0 0·7 NS
Liver
Total SFA 38·1a 0·5 25·3b 0·7 30·6c 0·5 27·2d 0·6 P,0·0001
Total MUFA 21·5a 1·3 12·9b 0·4 14·8b 0·5 13·7b 0·6 P,0·0001
Total PUFA 40·4a 1·0 61·8b 0·6 54·7b 0·7 59·2b 0·5 P,0·0001
PUFA n-6 33·3a 0·8 58·8b 0·8 31·7a 0·7 44·4c 0·3 P,0·0001
C18 : 2n-6 (LA) 14·4a 0·3 35·2b 0·9 18·7c 0·7 27·0d 0·5 P,0·0001
C18 : 3n-6 0·2a 0·0 0·7b 0·0 0·2a 0·0 0·3c 0·0 P,0·0001
C20 : 3n-6 0·8a 0·1 1·3b 0·1 1·1c 0·0 1·0c 0·1 P¼0·0001
C20 : 4n-6 (AA) 16·7a 0·6 16·8a 0·5 11·1b 0·6 14·5c 0·5 P,0·0001
C22 : 4n-6 0·7a 0·1 2·8b 0·0 0·1c 0·0 0·5d 0·0 P,0·0001
PUFA n-3 7·1a 0·3 3·0b 0·2 22·9c 1·1 14·8d 0·3 P,0·0001
C18 : 3n-3 (ALA) 0·4a 0·0 0·3a 0·0 8·8b 0·5 4·8c 0·2 P,0·0001
C20 : 5n-3 (EPA) 0·1a 0·0 0·1a 0·0 3·9b 0·4 1·3c 0·1 P,0·0001
C22 : 5n-3 0·7a 0·0 0·3a 0·0 3·4b 0·3 2·4c 0·1 P,0·0001
C22 : 6n-3 (DHA) 5·2a 0·3 2·2b 0·1 6·2c 0·2 6·0c 0·3 P,0·0001
EWAT
Total SFA 31·3a 0·3 20·6b 0·5 19·7b 0·4 19·1b 0·2 P,0·0001
Total MUFA 47·9a 0·3 27·2b 0·3 30·0c 0·2 27·5b 0·3 P,0·0001
Total PUFA 20·8a 0·4 52·2b 0·7 50·3c 0·5 53·3b 0·4 P,0·0001
PUFA n-6 19·1a 0·3 50·8b 0·7 22·9c 0·7 37·6d 0·4 P,0·0001
C18 : 2n-6 (LA) 18·4a 0·3 48·9b 0·7 22·2c 0·5 36·5d 0·4 P,0·0001
C18 : 3n-6 – – 0·1a 0·0 – – 0·1b 0·0 P,0·05
C20 : 3n-6 – – 0·2a 0·0 – – 0·1b 0·0 P,0·01
C20 : 4n-6 (AA) 0·4a 0·0 1·1b 0·1 0·5a 0·1 0·6a 0·0 P,0·0001
C22 : 4n-6 0·1a 0·0 0·2b 0·0 – – 0·1a 0·0 P,0·0001
PUFA n-3 1·7a 0·2 1·4a 0·1 27·4b 1·1 15·7c 0·6 P,0·0001
C18 : 3n-3 (ALA) 1·6a 0·2 1·3a 0·1 26·1b 1·2 14·6c 0·6 P,0·0001
C20 : 5n-3 (EPA) – – – – 0·4a 0·1 0·3b 0·0 P,0·05
C22 : 5n-3 – – – – 0·4 0·0 0·3 0·0 NS
C22 : 6n-3 (DHA) 0·1a 0·0 0·1a 0·0 0·3b 0·0 0·4b 0·0 P,0·0001
LA, linoleic acid; AA, arachidonic acid; ALA, a-linolenic acid; EWAT, epididymal white adipose tissue.
a,b,c,dMean values with unlike superscript letters were signiﬁcantly different by a post hoc pairwise comparison (P,0·05).
* Values are expressed as a percentage of total fatty acids.
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content of the HF diet, i.e. total LA þ ALA content, rather than
LA, ALA or the ratio of LA:ALA (and hence the n-6:n-3 fatty
acid ratio) that is important in the dual effects of these high
PUFA diets in increasing lean mass and in reducing fat mass.
Furthermore, our studies demonstrate that these HF diets
rich in LA and/or ALA improve whole-body insulin sensitivity,
also independently of the LA:ALA (and hence n-6:n-3 fatty
acid) ratio.
Relationship between PUFA precursors and body
composition
Further analysis of the body composition data using semi-syn-
thetic HF diets indicates the relationships between total PUFA
(LA þ ALA) content v. lean mass and fat mass that are best
ﬁtted by quadratic regression models, with threshold values
for an impact on body composition corresponding to between
25 and 30% of energy intake as total LA þ ALA content.
For the relationship between change in lean mass (y)
and PUFA intake (x), the equation is as follows: y ¼ y0
þ ax þ bx 2, where y0 ¼ 1·078, a ¼ 20·235 and b ¼ 0·013.
For the relationship between change in fat mass (y) and
PUFA intake (x), the equation is as follows: y ¼ y0 þ ax
þ bx 2, where y0 ¼ 22·640, a ¼ 0·453 and b ¼ 20·019.
Support for these regression models can also be derived
from other data on lean mass or fat mass obtained by iso-
energetic refeeding on synthetic diets (study III) in which
PUFA varied between 11 and 31% of energy intake: the
changes in lean and fat mass relative to a HF-lard diet are
close to those predicted by the quadratic regression models.
Another feature of this close ﬁt between model prediction
and measured values is that, because the synthetic diets
were formulated to keep MUFA content low and constant, it
reinforces the contention here that these relationships
between body composition and dietary fatty acid composition
are speciﬁcally related to total PUFA content rather than to
MUFA content of the diet. In other words, the differential
effects on body composition observed with the diets that
follow the quadratic models are explained by variations in
PUFA and not by variations in MUFA (study III), nor in SFA,
which is practically a constant in study I (Expt 2). Further-
more, in the latter study, the HF rapeseed oil with the
lowest SFA (5·5%) had no effect on body composition relative
to the HF-lard diet high in SFA (25%).
Impact of PUFA elongation–desaturation products
To what extent these effects of high-PUFA diets on body com-
position can be attributed to dietary LA or ALA in their own
right or to their elongation–desaturation products is not
known. Our analysis of the fatty acid composition of the
liver, adipose tissue and skeletal muscle indicates that
although most of the increases in PUFA in these key tissue/
organs reﬂect the high dietary LA or ALA content of the
diets, some of their respective metabolites were nonetheless
increased signiﬁcantly, with adipose tissue showing signiﬁcant
increases in AA in response to the LA-enriched diets or in EPA
and DHA in response to the ALA-enriched diets. Furthermore,T
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the ﬁndings here that isoenergetic refeeding with diets made
from ARASCO and DHASCO (high in AA and DHA, respect-
ively) also resulted in an increase (albeit marginal) in protein
gain and marked decrease in body-fat gain suggest that at least
some of the effects of LA and ALA on body composition might
be mediated by their elongated products. It is to be noted that
these diets enriched in AA or DHA provided less total PUFA
than those rich in LA and/or ALA (25–29% v. 30–42%, as
shown in Table 2). Nonetheless, the effects of diets made
from ARASCO and DHASCO on body composition are pre-
dicted by the quadratic model relating total PUFA content to
the lean mass and but not to the fat mass. These marked devi-
ations in fat mass reduction by these oils thus underlie the
more potent effects of AA and DHA in reducing fat mass
than their respective precursors LA and ALA. The ﬁndings
here of a more pronounced anti-adiposity effect of AA and
DHA than the respective precursor during catch-up growth
are in line with studies in spontaneously growing rats. These
have shown that (1) dietary g-LA – an elongated and desatu-
rated product of LA and an immediate precursor of AA – in
the form of borage oil causes less body fat accumulation
than LA in the form of safﬂower oil(33), and that (2) concen-
trates of n-3 PUFA of marine origin and rich in DHA had
more pronounced effects in reducing adiposity in mice than
n-3 ALA or n-6 LA precursors in the form of linseed oil, perilla
oil or safﬂower oil(34,35). Whether AA has more potent effects
than its immediate n-6 PUFA precursor g-LA on body compo-
sition is not known, but there is increasing evidence that DHA
and its immediate n-3 PUFA precursor EPA may differ con-
siderably in their effects on both fat mass and lean mass.
Indeed, using long-chain n-3 PUFA concentrates that differed
in the EPA:DHA ratio, it has also been shown that the protec-
tive effect of n-3 PUFA on adipose tissue accretion in mice was
stronger with DHA than with EPA(35,36). These data are consist-
ent with our past study indicating that refeeding on HF diets
made from menhaden ﬁsh oil, which is high in EPA but rela-
tively low in DHA, failed to reduce body fat accumulation,
and, in addition, led to reduced lean body mass accretion rela-
tive to HF diets rich in lard or olive oil(26). Thus, the effects of
n-6 or n-3 PUFA on body composition depend not only on
total PUFA contents in the diet but also on the proportion of
their speciﬁc elongated–desaturated products. However, our
ﬁndings that most of the increases in PUFA in key tissues/
organs reside in increases in LA and/or ALA raise the possi-
bility that these essential fatty acids themselves may be directly
involved in the mechanisms by which diets rich in LA and/or
ALA improve body composition during catch-up growth.
High-PUFA oils and insulin sensitivity
The present studies also provide insights into the effects of HF
diets made from oils rich in LA and/or ALA and their main
elongation–desaturation products (AA and DHA) in the
modulation of blood glucose homeostasis during catch-up
growth, a state of hyperinsulinaemia even on a low-fat diet
and exacerbated by a HF-lard diet(24). The results obtained
during the test of glucose tolerance, indicating that the
groups refed on the HF diets enriched in LA and/or ALA
show no alterations in plasma glucose but markedly reduced
plasma insulin in response to a glucose load, suggest that
these diets enriched in essential fatty acids are equally effec-
tive in improving insulin sensitivity. By contrast, this test
also revealed higher glucose responses and, to a lesser
extent, higher insulin responses observed with diets rich in
ARASCO. Furthermore, unlike HF diets made from safﬂower
or linseed oils, the diets high in ARASCO or DHASCO did
not result in a lower plasma insulin response curve below
that of the HF-lard group. Thus, whereas diets very high in
ARASCO and DHASCO had a marginal effect on lean mass
accretion and a marked effect on body fat, they failed to
improve glucose homeostasis, with the diet high in ARASCO
resulting in more pronounced hyperglycaemia relative to the
other diets in response to a glucose load.
Outcome of screening high-PUFA diets
Based on an overall analysis of body composition changes in
the context of isoenergetic refeeding on PUFA-enriched HF
diets, it can be concluded that of all oils screened, the
lowest rate of catch-up fat is observed with diets made from
safﬂower oil, linseed oil, ARASCO oil and DHASCO. However,
it is also evident that whereas the lower rate of catch-up fat
Table 10. Effects of high-fat (HF) diets made from different mixtures of microbial oils rich in arachidonic acid single cell oil (A) or docosahexaenoic acid
single cell oil (D) on body weight and body composition, as well as on plasma glucose and insulin in response to a glucose load
(Mean values with their standard errors, n 6)
Body composition Glucose tolerance test
Body weight (g) Water (g) Fat (g) Lean (g) Fat:lean Glucose (AUC)* Insulin (AUC)*
Group HF diet Mean SE Mean SE Mean SE Mean SE Mean SE Mean SE Mean SE
1 HF A:D (0:1) 335 7 217 5 42·3 1·5 75·9 1·5 0·55 0·02 4162a 718 297 53
2 HF A:D (1:3) 352 5 231 4 43·5 2·2 77·8 1·2 0·56 0·04 3622a 721 303 56
3 HF A:D (1:1) 349 3 230 3 41·4 1·8 77·7 1·2 0·53 0·03 5341a,b 379 366 35
4 HF A:D (3:1) 350 4 228 3 44·4 1·4 77·3 0·8 0·58 0·02 7443a,b 1600 316 51
5 HF A:D (1:0) 342 5 225 5 41·7 2·3 75·7 1·3 0·55 0·04 12 105b 3114 347 56
ANOVA NS NS NS NS NS P,0·01 NS
a,bMean values with unlike superscript letters were signiﬁcantly different by a post hoc pairwise comparison (P,0·05).
* AUC refers to the area under the curve for plasma glucose (mg/ 100ml per 2 h) or insulin curve (ng/m per 2 h) above baseline (pre-glucose load) plasma levels.
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with diets made from ARASCO and DHASCO, albeit unaccom-
panied by an improvement in glucose homeostasis, resides
primarily in enhanced thermogenesis, that from diets made
from safﬂower or linseed oils (which are associated with
improved insulin sensitivity) resides primarily in an enhanced
energy partitioning towards lean mass accretion. Given the
high energy cost of protein accretion (and its maintenance)
as opposed to low energy cost of fat deposition and mainten-
ance particularly on HF diets, it can be calculated that about
two-thirds of the reduction in fat accretion during catch-up
fat result from a shift in energy partitioning towards lean
body mass, and the remaining one-third resides in enhanced
thermogenesis. While an enhanced sympathetic thyroid
action on peripheral tissues (via uncoupling protein 1 in
brown adipose tissue, Naþ, Kþ-ATPase in brown adipose
tissue, liver or muscle) has often been described in response
to feeding on diets high in PUFA(28,33–40), the mechanisms
by which high-PUFA diets contributing .25% of energy
intake enhance energy partitioning towards lean body mass
is a new avenue for further investigations. These mechanisms
could implicate increased secretion and/or increased sensi-
tivity to the anabolic effects of numerous hormones known
to favour lean tissue accretion (e.g. insulin, insulin-like
growth factor-1 and growth hormone, thyroid-stimulating hor-
mone and thyroid hormones, catecholamines and testoster-
one) or decreased sensitivity to other hormones whose
actions lead to reduce lean mass (e.g. myostatin and IL-15).
Further studies are also warranted to investigate whether (1)
the ability of these diets enriched in essential fatty acids to
modulate body composition, shown here during refeeding
in male rats after post-weaning food restriction, can also be
demonstrated in female rats and in animal models of catch-
up growth after intra-uterine or neonatal malnutrition, and
(2) whether improvements in body composition during
catch-up growth in these models would have a long-term
impact on susceptibility to metabolic diseases later in life.
Conclusions and clinical implications
Infants and children with faltered growth often have poor
appetite, particularly under conditions of malnutrition
infections. Consequently, the high energy requirements for
catch-up growth can only be achieved with energy-dense for-
mulations, which in turn impose a need for a HF content(41),
an important factor that promotes excessive adiposity and
insulin resistance during catch-up growth. The present study
in the rat indicates that HF diets enriched with LA and/or
ALA have the potential to limit excessive accretion of body
fat while improving lean body mass and insulin sensitivity
during catch-up growth. That these improvements occur inde-
pendently of the dietary LA:ALA ratio and hence in the n-6:n-3
fatty acid ratio (ranging from ,1 to .40) is in line with the
view that challenges emphasis placed upon this ratio, rather
than in total n-3 and n-6 PUFA contents for clinical beneﬁts(42).
Whether diets providing such high PUFA intake, exceeding
25% of total energy intake, are safe and effective in modulat-
ing body composition and metabolic health in humans
are issues that must be considered with caution. There is,
however, evidence from trials in non-human primates demon-
strating cardiovascular beneﬁts, and no evidence of harm,
with LA intakes of 25% of energy for up to 5 years(43,44). In
humans, randomised trials with n-6 PUFA intakes (mostly as
LA) of 11–21% of energy for up to 11 years show reduced
risk for CHD and with no evidence of harm(45). It should
also be pointed out that the extrapolation of ﬁndings from
small rodents to humans should also take into account the
state of knowledge, indicating that the efﬁcacy of several
speciﬁc food ingredients that either stimulate thermogenesis
(e.g. caffeine, green tea catechins and medium-chain TAG)
or that shift nutrient partitioning in favour of lean tissue (e.g.
conjugated LA) has been demonstrated at much lower doses
in humans (albeit adults) than in laboratory rodents(27,46,47).
Further support for this contention, in the context of dietary
enrichment with essential fatty acids, can be derived from a
recent report(48) that supplementation with modest amounts
of LA-rich safﬂower oil resulted in reduced trunk fat and
increased lean mass in obese women with type 2 diabetes
mellitus. Taken together, the possibility therefore arises that
diets enriched with more modest amounts of PUFA as LA
and/or ALA than shown here to be effective in improving
body composition and insulin sensitivity in rats may have rel-
evance for improving body composition and insulin sensitivity
during catch-up growth in humans.
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